Clinical trial NCT00925717: of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
Official title: of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Low Density Lipoprotein Cholesterol Goal Achievement
Keywords: ADA recommendation
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2009-06-22
Enrollment: 4045
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Who have records of clinic visit with endocrine internal medicines of nationwide secondary/tertiary hospitals within the last six months.

Brief summary: An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.


Eligibility criteria: Inclusion Criteria:

* Subjects who was diagnosed as diabetes
* Subjects who was diagnosed as dyslipidaemia or takes lipid lowering medication
* Clinic visit in the past 6 months more than once

Exclusion Criteria:

* Subjects who are unwilling or unable to provide their examination and lab result of medical chart.

Primary outcomes:
measure: Investigate LDL-C goal achievement rate according to ADA recommendation
timeFrame: Within the last 6 months from the date of data entry.
Secondary outcomes:
measure: Investigate reduction of 10-year risk for CHD by using UKPDS risk engine
timeFrame: Within the last 6 months from the date of data entry.
Other outcomes:
Locations:
city: Cheonan-si
country: Korea, Republic of
facility: Research Site
state: Chungchungnam-do
city: Ansan-si
country: Korea, Republic of
facility: Research Site
state: Gyeonggi-do
city: Anyang-si
country: Korea, Republic of
facility: Research Site
state: Gyeonggi-do
city: Bucheon-si
country: Korea, Republic of
facility: Research Site
state: Gyeonggi-do
city: Goyang-si
country: Korea, Republic of
facility: Research Site
state: Gyeonggi-do
city: Seongnam-si
country: Korea, Republic of
facility: Research Site
state: Gyeonggi-do
city: Suwon-si
country: Korea, Republic of
facility: Research Site
state: Gyeonggi-do
city: Uijeongbu-si
country: Korea, Republic of
facility: Research Site
state: Gyeonggi-do
city: Gwangju-si
country: Korea, Republic of
facility: Research Site
state: Jeollanam-do
city: Suncheon
country: Korea, Republic of
facility: Research Site
state: Jeollanam-do
city: Jeonju-si
country: Korea, Republic of
facility: Research Site
state: Jeonllabuk-do
city: Chuncheon-si
country: Korea, Republic of
facility: Research Site
state: Kangwon-do
city: Chuncheon
country: Korea, Republic of
facility: Research Site
state: Kangwon-do
city: Kang-Neung
country: Korea, Republic of
facility: Research Site
state: Kangwon-do
city: Wonju-si
country: Korea, Republic of
facility: Research Site
state: Kangwon-do
city: Busan-si
country: Korea, Republic of
facility: Research Site
city: Cheonju-si
country: Korea, Republic of
facility: Research Site
city: Daegu-si
country: Korea, Republic of
facility: Research Site
city: Daejeon-si
country: Korea, Republic of
facility: Research Site
city: Incheon-si
country: Korea, Republic of
facility: Research Site
city: Incheon
country: Korea, Republic of
facility: Research Site
city: Jeonju-si
country: Korea, Republic of
facility: Research Site
city: Kwangju-si
country: Korea, Republic of
facility: Research Site
city: Seoul
country: Korea, Republic of
facility: Research Site
Study officials:
affiliation: Samsung Medical Center
name: MoonGyu Lee, Ph.D.
role: STUDY_DIRECTOR
References: